87 Xiangya Rd, 
Changsha, CN 

Overview

Zhenyu Yang practices practicing medicine in Changsha, China.

Their clinical expertise encompasses Colitis, Viral Gastroenteritis, Prostate Cancer, and Crohn's Disease.

They are actively involved in clinical research, co-authoring 28 peer reviewed articles.

Locations

87 Xiangya Rd, Changsha, 410008, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Frequently Asked Questions about Zhenyu Yang

Is Zhenyu Yang a top-rated expert for Colitis?

MediFind is an objective health platform that identifies experts based on real-world data. Zhenyu Yang is classified as an Experienced expert for Colitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Zhenyu Yang participate in research or clinical trials?

Yes. Zhenyu Yang has published 28 articles and abstracts on conditions like Colitis. You can view a list of Zhenyu Yang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yang's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile